Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Akt1. [electronic resource]
Producer: 20170626Description: 67-74 p. digitalISSN:- 1872-6240
- Animals
- Apoptosis -- drug effects
- Brain Ischemia -- complications
- Caspase 3 -- metabolism
- Cilostazol
- Cognition Disorders -- drug therapy
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Enzyme Inhibitors -- pharmacology
- Hippocampus -- drug effects
- Male
- Mitogen-Activated Protein Kinase 10 -- antagonists & inhibitors
- Neurons -- drug effects
- Neuroprotective Agents -- pharmacology
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Rats, Sprague-Dawley
- Reperfusion Injury -- complications
- Tetrazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.